OSR Health Issues Clarification Regarding Prior Nasdaq Communication and Shareholder Loyalty CVR Program

OSR Health clarified that Nasdaq has not approved or endorsed its Shareholder Loyalty CVR Program, correcting a misleading statement made in a prior press release. The company specified that Nasdaq's previous communication was only a preliminary verbal indication regarding technical price adjustments, not a definitive opinion on the program itself.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.